Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance
NCT04853186 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2024-09-19
Summary
This project aims to fill this essential knowledge gap by assessing the impact of oral cholera vaccine mass campaigns in 2 sites (urban and rural) in DRC, described in this protocol. The evidence generated from this project will be key to develop future strategies regarding cholera vaccine use in endemic settings, including places with higher burden in terms of cholera mortality.
Conditions
- Cholera
Sponsors & Collaborators
-
Wellcome Trust
collaborator OTHER -
Médecins Sans Frontières, France
collaborator OTHER -
Ministry of Public Health, Democratic Republic of the Congo
collaborator OTHER_GOV -
Institut National de Recherche Biomédicale. Goma, République Démocratique du Congo
collaborator UNKNOWN -
Grand Labo de Lubumbashi
collaborator UNKNOWN -
Epicentre
lead OTHER
Principal Investigators
-
Klaudia PORTEN · Epicentre
-
Francesco Luquero · GAVI
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-11
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Democratic Republic of the Congo
Study Locations
More Related Trials
-
A Baseline Study in Support of Clinical Evaluation of an Oral Shigella Vaccine Development in Africa
NCT04312906 ·Status: COMPLETED
-
Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine
NCT03373669 ·Status: COMPLETED ·Phase: PHASE4
-
Introduction of Cholera Vaccine in Bangladesh
NCT01339845 ·Status: COMPLETED ·Phase: NA
-
Cholera Vaccine Investment Strategy in Bangladesh
NCT02727855 ·Status: COMPLETED
-
An Epidemiological Surveillance Study to Determine the Incidence of ETEC in Children and Infants in Lusaka
NCT04838587 ·Status: COMPLETED
-
Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)
NCT04423159 ·Status: COMPLETED ·Phase: NA
-
Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh
NCT02027207 ·Status: COMPLETED ·Phase: PHASE3
-
Vaccine- and Infection-derived Correlates of Protection for Cholera
NCT06455852 ·Status: RECRUITING ·Phase: NA
-
Zinc Supplementation in Cholera Patients
NCT00226616 ·Status: COMPLETED ·Phase: PHASE3
-
To Determine the Safety and Immunogenicity of an Oral Whole Cell ShanChol Cholera Vaccine in Bangladesh
NCT01042951 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Cholera Vaccine Delivery in Rural Bangladesh
NCT01811771 ·Status: COMPLETED ·Phase: NA
-
Reservoir of Invasive Salmonellosis in Children, DRC
NCT03073707 ·Status: COMPLETED
-
SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
NCT03313128 ·Status: COMPLETED
-
Field Application of Shanchol in Adults in Bangladesh
NCT01762930 ·Status: COMPLETED ·Phase: PHASE2
-
Studies of Immune Responses to Orally Administered Vaccines in Developing Country
NCT01019083 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Estimate the Disease Burden of Acute Rotavirus Gastroenteritis in Children < 5 Years in United Arab Emirates
NCT01201252 ·Status: COMPLETED
-
Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules)
NCT03237663 ·Status: COMPLETED ·Phase: PHASE1
-
Mortality Reduction After Oral Azithromycin: Morbidity Study
NCT02048007 ·Status: COMPLETED ·Phase: PHASE4
-
Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon
NCT05684887 ·Status: COMPLETED ·Phase: NA
-
Effect of Probiotic on Immunogenicity of Oral Cholera Vaccine
NCT00464867 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Multiple Behaviour Programme for Diarrhoea Management
NCT02081521 ·Status: COMPLETED ·Phase: NA
-
InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
NCT05961059 ·Status: RECRUITING ·Phase: PHASE1
-
Contagious Misinformation Trial
NCT04112680 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study Examining for the Presence of Fecal Coliforms and Tropical Diseases in Peru
NCT03078894 ·Status: UNKNOWN
-
Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)
NCT06003816 ·Status: RECRUITING ·Phase: NA